PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $327,715 | +1.8% | 31,909 | 0.0% | 0.08% | +47.3% |
| Q3 2022 | $322,000 | +0.6% | 31,909 | 0.0% | 0.06% | -17.9% |
| Q2 2022 | $320,000 | 0.0% | 31,909 | 0.0% | 0.07% | -10.7% |
| Q1 2022 | $320,000 | +53.8% | 31,909 | +52.1% | 0.08% | -2.6% |
| Q4 2021 | $208,000 | – | 20,984 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 108,103 | $1,177,782 | 0.32% |
| METEORA CAPITAL, LLC | 169,897 | $1,841,683 | 0.31% |
| Mint Tower Capital Management B.V. | 141,089 | $1,532 | 0.24% |
| BERKLEY W R CORP | 47,199 | $512,581 | 0.03% |
| Shaolin Capital Management LLC | 50,000 | $543 | 0.02% |
| CLEAR STREET LLC | 73,364 | $797 | 0.01% |
| Walleye Capital LLC | 47,936 | $520,585 | 0.00% |
| Walleye Trading LLC | 26,964 | $292,829 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,588 | $114,985 | 0.00% |